UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 20, 2025
Accession Number:
0001213900-25-044891
Submission Type:
POS AM
CIK:
0001173313
Company Name:
ABVC BIOPHARMA, INC.
File Number:
333-271416